Cargando…
A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice
New antidepressant pharmacotherapies that provide rapid relief of depressive symptoms are needed. The NMDA receptor antagonist ketamine exerts rapid antidepressant actions in depressed patients but also side effects that complicate its clinical utility. Ketamine promotes excitatory synaptic strength...
Autores principales: | Zanos, Panos, Nelson, Mackenzie E., Highland, Jaclyn N., Krimmel, Samuel R., Georgiou, Polymnia, Gould, Todd D., Thompson, Scott M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Neuroscience
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334634/ https://www.ncbi.nlm.nih.gov/pubmed/28275719 http://dx.doi.org/10.1523/ENEURO.0285-16.2017 |
Ejemplares similares
-
Sex-Specific Involvement of Estrogen Receptors in Behavioral Responses to Stress and Psychomotor Activation
por: Georgiou, Polymnia, et al.
Publicado: (2019) -
Hydroxynorketamine: Implications for the NMDA Receptor Hypothesis of
Ketamine’s Antidepressant Action
por: Aleksandrova, Lily R., et al.
Publicado: (2017) -
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
por: Zanos, Panos, et al.
Publicado: (2016) -
Involvement of NMDA receptors containing the GluN2C subunit in the psychotomimetic and antidepressant-like effects of ketamine
por: Tarrés-Gatius, Mireia, et al.
Publicado: (2020) -
Allosteric Site Mediates Inhibition of Tonic NMDA Receptor Activity by Low Dose Ketamine
por: Popescu, Gabriela, et al.
Publicado: (2023)